Comprehensive Eye Exams

New research reveals collagen mimetic peptides may effectively restore ocular tissue stiffness, offering hope for myopia and other eye diseases.

These screening solutions will work to make early detection of diabetic retinopathy easier with on-the-spot screening.

Explaining how different examinations are billed by insurance to patients can make a difference in patient care.

In this podcast, experts Quan Dong Nguyen, MD, MSc; and Cecelia Koetting, OD, FAAO, DipABO; discuss the diagnosis, staging, and treatment of NK, focusing on early-stage disease.

In this podcast, experts Deborah Ristvedt, DO; and Melissa Tawa, OD, FAAO, discuss individualizing glaucoma therapy with selective laser trabeculoplasty and sustained-release drug implants, providing key take-home insights for optimizing glaucoma management across diverse patient profiles.

Embracing new technology is good for patients and provides protection against malpractice claims.

Maggie Cline, MPH, initially joined the organization in 2022 and served as Executive Director Utah.

The report highlights clinical successes, innovation, research, and patient outcomes.

Bryce St Clair, OD, MPH, authors the June edition of the Cultural Responsiveness Blog, and urges doctors to consider cultural and socioeconomic backgrounds when caring for patients.

Erin Tomiyama, OD, PhD, FAAO, offers actionable advice for myopia management and perspective for practitioners ready to refine their approach.

An official approval by the FDA in the United States can boost adoption rate of atropine and antimyopia glasses, which will change the landscape of myopia management.

The qVPT, a suprathreshold test comprised of 15 trials at 9 cycles per degree and 20% contrast, measures the patient’s response time to visual stimuli and the number of correct responses.

Mark Bullimore, MCOptom, PhD, details the importance of preparing optometric students for myopic patient care in a Collaborative Care Symposium (CCS) 2025 presentation.

In this Q&A, John D. Gelles, OD, and Steven Greenstein, MD, chat about what inspired them to launch the symposium, what makes this year’s agenda especially exciting, and why the future of refractive care depends on stronger collaboration between ODs and MDs.

Digital Twin and VESA can integrate refractive data, topography, biomechanical properties, and even simulate age-related changes in the eye—turning it into a predictive and diagnostic tool for clinicians managing complex conditions like presbyopia.

The Early Detection of Vision Impairments for Children Act (EDVI), or HR 2527, would allow the federal government to award grants and cooperative agreements to eligible states and communities for children's vision care initiatives.

Insurance coverage from the second largest health plan in the US paves the way for expanded access to Luminopia’s unique amblyopia therapeutic.

Investigators reported that the benefits of the training for patients with hemianopia, driven by improved blind-side scanning, lasted for more than a month.

While the study included a range of patients in a variety of stages of presbyopia, the change in crystalline lens and anterior segment geometry was most pronounced in emmetropic and myopic presbyopes.

According to a press release, Myatro XL is the first 0.05% atropine eye drop for pediatric myopia control. It will be commercially available in India in July 2025.

The report outlines views and behaviors of US adults regarding vision correction, managed vision care, eye examinations, prescription eyewear, reading glasses, and nonprescription sunglasses.